Views & Analysis
JPM: Four ways FDA is seeking to buoy gene therapy
On the outskirts of the JP Morgan Healthcare Conference today, FDA's Dr Peter Marks discussed how to get more gene therapies approved in 2024.
Monday 10 August 2026
